Icon

PATANASE (nda021861)- (0.665MG/SPRAY)

OLOPATADINE HYDROCHLORIDE NOVARTIS
0.665MG/SPRAY
Yes No
2023-Aug-02 Expired
None None
None No
PATANASE is an H1 receptor antagonist indicated for the relief of the symptoms of seasonal allergic rhinitis in adults and pediatric patients 6 years of age and older.
4 0 4
Total Other Developers 3
Drugs with Suitability No
0.665MG/SPRAY ** ** - - 3
NDA Sales Available Total Generic Sales Available
Yes 4
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ****** *** ****** ***. *********** *** ****** *****, *******, ******* *** ***, ****** (***) ***
****** ******* ****** ******* ****** *************** *** *********** * ********* ***, *******, *******, ****** (***) ***
****** ****** ****** ***************, *** *********** *** ******** ***** ** **** *, **********, *** ****** (**) *****-****, ****** ****** (***) ***
****** ***** ***** ********* ******* *** (*** *****) *********** *** ******* ******, **********, *** **** (**) *****, ****** ****** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.